1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1-133.
[CROSSREF] [PUBMED] [PMC]
2. Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 2010;20:135-146.
[CROSSREF] [PUBMED]
3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526-534.
[CROSSREF] [PUBMED]
4. Lam E, Strugnell SS, Bajdik C, Holmes D, Wiseman SM. Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre. Can J Surg 2013;56:385-392.
[CROSSREF] [PUBMED] [PMC] [PDF]
5. Giusti M, Mortara L, Machello N, Monti E, Pera G, Marenzana M. Utility of a liquid formulation of levo-thyroxine in differentiated thyroid cancer patients. Drug Res (Stuttg) 2015;65:332-336.
[CROSSREF] [PUBMED] [PDF]
6. Batrinos ML. The problem of exogenous subclinical hyperthyroidism. Hormones (Athens) 2006;5:119-125.
[CROSSREF] [PUBMED]
7. Santini F, Pinchera A, Marsili A, Ceccarini G, Castagna MG, Valeriano R, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 2005;90:124-127.
[CROSSREF] [PUBMED]
8. Skelin M, Lucijanic T, Amidzic Klaric D, Resic A, Bakula M, Liberati-Cizmek AM, et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther 2017;39:378-403.
[CROSSREF] [PUBMED]
9. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010;11:41-50.
[CROSSREF] [PUBMED]
10. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017;27:315-389.
[CROSSREF] [PUBMED]
11. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-956.
[CROSSREF] [PUBMED]
12. Gurnell M, Halsall DJ, Chatterjee VK. What should be done when thyroid function tests do not make sense? Clin Endocrinol (Oxf) 2011;74:673-678.
[CROSSREF] [PUBMED]
13. Sakai H, Fukuda G, Suzuki N, Watanabe C, Odawara M. Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocr J 2009;56:435-440.
[CROSSREF] [PUBMED]
14. Rix M, Laurberg P, Porzig C, Kristensen SR. Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex. Acta Paediatr 2011;100:e135-e137.
[CROSSREF] [PUBMED]
15. Loh TP, Kao SL, Halsall DJ, Toh SA, Chan E, Ho SC, et al. Macro-thyrotropin: a case report and review of literature. J Clin Endocrinol Metab 2012;97:1823-1828.
[CROSSREF] [PUBMED] [PDF]
16. Samson SL, Hamrahian AH, Ezzat S. AACE Neuroendocrine and Pituitary Scientific Committee. American College of Endocrinology (ACE). American Association of Clinical Endocrinologists, American College of Endocrinology Disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract 2015;21:1427-1435.
[CROSSREF] [PUBMED]
17. Hattori N, Ishihara T, Yamagami K, Shimatsu A. Macro TSH in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf) 2015;83:923-930.
[CROSSREF] [PUBMED]
18. Hattori N, Ishihara T, Shimatsu A. Variability in the detection of macro TSH in different immunoassay systems. Eur J Endocrinol 2016;174:9-15.
[CROSSREF] [PUBMED]
19. Hattori N, Ishihara T, Matsuoka N, Saito T, Shimatsu A. Anti-thyrotropin autoantibodies in patients with macro-thyrotropin and long-term changes in macro-thyrotropin and serum thyrotropin levels. Thyroid 2017;27:138-146.
[CROSSREF] [PUBMED]
20. Kadoya M, Koyama S, Morimoto A, Miyoshi A, Kakutani M, Hamamoto K, et al. Serum macro TSH level is associated with sleep quality in patients with cardiovascular risks: HSCAA Study. Sci Rep 2017;7:44387
[CROSSREF] [PUBMED] [PMC] [PDF]
21. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002;87:5410-5415.
[CROSSREF] [PUBMED]
22. Ismail AA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr WA. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 2002;48:2023-2029.
[CROSSREF] [PUBMED] [PDF]
23. Lewis EJ, Lim R, Joseph F, Ewins D, Goenka N, Bowles SA, et al. Recognising macro-TSH: a rare cause of inappropriately high TSH values. Clin Chem Lab Med 2011;49(Suppl):S421.
24. Mills F, Jeffery J, Mackenzie P, Cranfield A, Ayling RM. An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration. Ann Clin Biochem 2013;50(Pt 5):416-420.
[CROSSREF] [PUBMED]
25. Sukumar R, Agarwal A, Gupta S, Mishra A, Agarwal G, Verma AK, et al. Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders. World J Surg 2010;34:527-531.
[CROSSREF] [PUBMED] [PDF]
26. Del Duca SC, Santaguida MG, Brusca N, Gatto I, Cellini M, Gargano L, et al. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study. Eur J Endocrinol 2015;173:351-357.
[CROSSREF] [PUBMED]